Long-term allopurinol use decreases the risk of prostate cancer in patients with gout: a population-based study
-J Huang (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 11, 2017 Category: Urology & Nephrology Authors: H-J Shih M-C Kao P-S Tsai Y-C Fan C-J Huang Source Type: research

Reply to 'Non-surgically related causes of erectile dysfunction after bilateral nerve-sparing radical prostatectomy'
Cakir (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 11, 2017 Category: Urology & Nephrology Authors: M G Culha O O Cakir Source Type: research

Trends in the use of radiation therapy for stage IIA prostate cancer from 2004 to 2013: a retrospective analysis using the National Cancer Database
berstein (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 11, 2017 Category: Urology & Nephrology Authors: T Malouff N W Mathy S Marsh R W Walters P T Silberstein Source Type: research

Long-term allopurinol use decreases the risk of prostate cancer in patients with gout: a population-based study
-J Huang (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 11, 2017 Category: Urology & Nephrology Authors: H-J Shih M-C Kao P-S Tsai Y-C Fan C-J Huang Source Type: research

Extracellular vesicles for liquid biopsy in prostate cancer: where are we and where are we headed ?
Extracellular vesicles for liquid biopsy in prostate cancer: where are we and where are we headed? Prostate Cancer and Prostatic Diseases advance online publication, April 4 2017. doi:10.1038/pcan.2017.7 Authors: V R Minciacchi, A Zijlstra, M A Rubin & D Di Vizio (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 4, 2017 Category: Urology & Nephrology Authors: V R Minciacchi A Zijlstra M A Rubin D Di Vizio Source Type: research

Extracellular vesicles for liquid biopsy in prostate cancer: where are we and where are we headed?
i Vizio (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 4, 2017 Category: Urology & Nephrology Authors: V R Minciacchi A Zijlstra M A Rubin D Di Vizio Source Type: research

Impact of urologists ’ ownership of radiation equipment in the treatment of prostate cancer
Impact of urologists’ ownership of radiation equipment in the treatment of prostate cancer Prostate Cancer and Prostatic Diseases advance online publication, March 28 2017. doi:10.1038/pcan.2017.9 Authors: S B Williams, J Huo, B F Chapin, B D Smith & K E Hoffman (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 28, 2017 Category: Urology & Nephrology Authors: S B Williams J Huo B F Chapin B D Smith K E Hoffman Source Type: research

Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus Project
& T J Polascik (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 28, 2017 Category: Urology & Nephrology Authors: K J Tay M J Scheltema H U Ahmed E Barret J A Coleman J Dominguez-Escrig S Ghai J Huang J S Jones L H Klotz C N Robertson R Sanchez-Salas S Scionti A Sivaraman J de la Rosette T J Polascik Source Type: research

Androgen deprivation therapy for prostate cancer and dementia risk: a systematic review and meta-analysis
Nguyen (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 28, 2017 Category: Urology & Nephrology Authors: K T Nead S Sinha P L Nguyen Source Type: research

Impact of urologists ’ ownership of radiation equipment in the treatment of prostate cancer
Impact of urologists’ ownership of radiation equipment in the treatment of prostate cancer Prostate Cancer and Prostatic Diseases advance online publication, March 28 2017. doi:10.1038/pcan.2017.9 Authors: S B Williams, J Huo, B F Chapin, B D Smith & K E Hoffman (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 28, 2017 Category: Urology & Nephrology Authors: S B Williams J Huo B F Chapin B D Smith K E Hoffman Source Type: research

Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus Project
& T J Polascik (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 28, 2017 Category: Urology & Nephrology Authors: K J Tay M J Scheltema H U Ahmed E Barret J A Coleman J Dominguez-Escrig S Ghai J Huang J S Jones L H Klotz C N Robertson R Sanchez-Salas S Scionti A Sivaraman J de la Rosette T J Polascik Source Type: research

Celastrol, an active constituent of the TCM plant Tripterygium wilfordii Hook.f., inhibits prostate cancer bone metastasis
in & T Pan (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 28, 2017 Category: Urology & Nephrology Authors: K Kuchta Y Xiang S Huang Y Tang X Peng X Wang Y Zhu J Li J Xu Z Lin T Pan Source Type: research

Androgen deprivation therapy for prostate cancer and dementia risk: a systematic review and meta-analysis
Nguyen (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 28, 2017 Category: Urology & Nephrology Authors: K T Nead S Sinha P L Nguyen Source Type: research

ProPSA and the Prostate Health Index as predictive markers for aggressiveness in low-risk prostate cancer — results from an international multicenter study
ProPSA and the Prostate Health Index as predictive markers for aggressiveness in low-risk prostate cancer—results from an international multicenter study Prostate Cancer and Prostatic Diseases advance online publication, March 21 2017. doi:10.1038/pcan.2017.3 Authors: I Heidegger, H Klocker, R Pichler, A Pircher, W Prokop, E Steiner, C Ladurner, E Comploj, A Lunacek, D Djordjevic, A Pycha, E Plas, W Horninger & J Bektic (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 21, 2017 Category: Urology & Nephrology Authors: I Heidegger H Klocker R Pichler A Pircher W Prokop E Steiner C Ladurner E Comploj A Lunacek D Djordjevic A Pycha E Plas W Horninger J Bektic Source Type: research

ProPSA and the Prostate Health Index as predictive markers for aggressiveness in low-risk prostate cancer —results from an international multicenter study
ProPSA and the Prostate Health Index as predictive markers for aggressiveness in low-risk prostate cancer—results from an international multicenter study Prostate Cancer and Prostatic Diseases advance online publication, March 21 2017. doi:10.1038/pcan.2017.3 Authors: I Heidegger, H Klocker, R Pichler, A Pircher, W Prokop, E Steiner, C Ladurner, E Comploj, A Lunacek, D Djordjevic, A Pycha, E Plas, W Horninger & J Bektic (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 21, 2017 Category: Urology & Nephrology Authors: I Heidegger H Klocker R Pichler A Pircher W Prokop E Steiner C Ladurner E Comploj A Lunacek D Djordjevic A Pycha E Plas W Horninger J Bektic Source Type: research

Imaging response during therapy with radium-223 for castration-resistant prostate cancer with bone metastases — analysis of an international multicenter database
Imaging response during therapy with radium-223 for castration-resistant prostate cancer with bone metastases—analysis of an international multicenter database Prostate Cancer and Prostatic Diseases advance online publication, February 28 2017. doi:10.1038/pcan.2017.6 Authors: D Keizman, M O Fosboel, H Reichegger, A Peer, E Rosenbaum, M-C Desax, V Neiman, P M Petersen, J Mueller, R Cathomas, M Gottfried, H Dresler, D Sarid, W Mermershtain, K Rouvinov, J Mortensen, S Gillessen, G Daugaard & A Omlin (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 28, 2017 Category: Urology & Nephrology Authors: D Keizman M O Fosboel H Reichegger A Peer E Rosenbaum M-C Desax V Neiman P M Petersen J Mueller R Cathomas M Gottfried H Dresler D Sarid W Mermershtain K Rouvinov J Mortensen S Gillessen G Daugaard A Omlin Source Type: research

Imaging response during therapy with radium-223 for castration-resistant prostate cancer with bone metastases —analysis of an international multicenter database
Imaging response during therapy with radium-223 for castration-resistant prostate cancer with bone metastases—analysis of an international multicenter database Prostate Cancer and Prostatic Diseases advance online publication, February 28 2017. doi:10.1038/pcan.2017.6 Authors: D Keizman, M O Fosboel, H Reichegger, A Peer, E Rosenbaum, M-C Desax, V Neiman, P M Petersen, J Mueller, R Cathomas, M Gottfried, H Dresler, D Sarid, W Mermershtain, K Rouvinov, J Mortensen, S Gillessen, G Daugaard & A Omlin (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 28, 2017 Category: Urology & Nephrology Authors: D Keizman M O Fosboel H Reichegger A Peer E Rosenbaum M-C Desax V Neiman P M Petersen J Mueller R Cathomas M Gottfried H Dresler D Sarid W Mermershtain K Rouvinov J Mortensen S Gillessen G Daugaard A Omlin Source Type: research

Impact of carbohydrate restriction in the context of obesity on prostate tumor growth in the Hi-Myc transgenic mouse model
Freedland (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 28, 2017 Category: Urology & Nephrology Authors: E H Allott E Macias S Sanders B S Knudsen G V Thomas S D Hursting S J Freedland Source Type: research

Impact of symptomatic skeletal events on health-care resource utilization and quality of life among patients with castration-resistant prostate cancer and bone metastases
p; P Kantoff (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 21, 2017 Category: Urology & Nephrology Authors: R McKay B Haider M S Duh A Valderrama M Nakabayashi M Fiorillo L Ristovska L Wen P Kantoff Source Type: research

TCF7 is suppressed by the androgen receptor via microRNA-1-mediated downregulation and is involved in the development of resistance to androgen deprivation in prostate cancer
mp; Y-N Liu (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 21, 2017 Category: Urology & Nephrology Authors: M K Siu W-Y Chen H-Y Tsai H-Y Chen J J Yin C-L Chen Y-C Tsai Y-N Liu Source Type: research

Meta-analysis of metabolic syndrome and prostate cancer
amp; S Serni (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 21, 2017 Category: Urology & Nephrology Authors: M Gacci G I Russo C De Nunzio A Sebastianelli M Salvi L Vignozzi A Tubaro G Morgia S Serni Source Type: research

The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy
od & P A Pinto (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 21, 2017 Category: Urology & Nephrology Authors: M Maruf M Fascelli A K George M M Siddiqui M Kongnyuy J M DiBianco A Muthigi S Valayil A Sidana T P Frye A Kilchevsky P L Choyke B Turkbey B J Wood P A Pinto Source Type: research

Celastrol, an active constituent of the TCM plant Tripterygium wilfordii Hook.f., inhibits prostate cancer bone metastasis
in & T Pan (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 14, 2017 Category: Urology & Nephrology Authors: K Kuchta Y Xiang S Huang Y Tang X Peng X Wang Y Zhu J Li J Xu Z Lin T Pan Source Type: research

Establishing the distribution of satellite lesions in intermediate- and high-risk prostate cancer: implications for focused radiotherapy
M Kamrava (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 31, 2017 Category: Urology & Nephrology Authors: J V Hegde D J Margolis P-C Wang R E Reiter J Huang M L Steinberg M Kamrava Source Type: research

The impact of comorbidity and PSA doubling time on the risk of death in men experiencing PSA failure following radiation therapy with or with androgen deprivation therapy for unfavorable-risk prostate cancer
V D'Amico (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 24, 2017 Category: Urology & Nephrology Authors: S A Patel M-H Chen M Loffredo A Renshaw P W Kantoff A V D'Amico Source Type: research

Use of the Prostate Health Index for detection of prostate cancer: results from a large academic practice
ll & A E Ross (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 24, 2017 Category: Urology & Nephrology Authors: J J Tosoian S C Druskin D Andreas P Mullane M Chappidi S Joo K Ghabili J Agostino K J Macura H B Carter E M Schaeffer A W Partin L J Sokoll A E Ross Source Type: research

Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAIL
ung & T M Beer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 24, 2017 Category: Urology & Nephrology Authors: A H Bryce J J Alumkal A Armstrong C S Higano P Iversen C N Sternberg D Rathkopf Y Loriot J de Bono B Tombal S Abhyankar P Lin A Krivoshik D Phung T M Beer Source Type: research

Formalin disinfection of prostate biopsy needles may reduce post-biopsy infectious complications
Roehrborn (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 24, 2017 Category: Urology & Nephrology Authors: N Singla J Walker S L Woldu N M Passoni K de la Fuente C G Roehrborn Source Type: research

Lifestyle guidelines for managing adverse effects on bone health and body composition in men treated with androgen deprivation therapy for prostate cancer: an update
Fraser (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 24, 2017 Category: Urology & Nephrology Authors: P J Owen R M Daly P M Livingston S F Fraser Source Type: research

Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancer
& F Y Feng (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 24, 2017 Category: Urology & Nephrology Authors: P L Nguyen N E Martin V Choeurng B Palmer-Aronsten T Kolisnik C J Beard P F Orio M D Nezolosky Y-W Chen H Shin E Davicioni F Y Feng Source Type: research

Is prostate cancer stage migration continuing for black men in the PSA era?
R Abern (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 17, 2017 Category: Urology & Nephrology Authors: R W Dobbs D T Greenwald H Wadhwa V L Freeman M R Abern Source Type: research

End-of-radiation PSA as a novel prognostic factor in patients undergoing definitive radiation and androgen deprivation therapy for prostate cancer
Y Song & P T Tran (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 17, 2017 Category: Urology & Nephrology Authors: A K Narang J Trieu N Radwan A Ram S P Robertson P He C Gergis E Griffith H Singh T A DeWeese S Honig A Annadanam S Greco C DeVille T McNutt T L DeWeese D Y Song P T Tran Source Type: research

Prognostic value of the new Grade Groups in Prostate Cancer: a multi-institutional European validation study
en & S F Shariat (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 10, 2017 Category: Urology & Nephrology Authors: R Mathieu M Moschini B Beyer K M Gust T Seisen A Briganti P Karakiewicz C Seitz L Salomon A de la Taille M Roupr êt M Graefen S F Shariat Source Type: research

Metformin and the risk of prostate cancer across racial/ethnic groups: a population-based cohort study
Johnson (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 10, 2017 Category: Urology & Nephrology Authors: C B Chen D T Eurich S R Majumdar J A Johnson Source Type: research

Unscreened older men diagnosed with prostate cancer are at increased risk of aggressive disease
& P C Walsh (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 3, 2017 Category: Urology & Nephrology Authors: J J Tosoian R Alam C Gergis A Narang N Radwan S Robertson T McNutt A E Ross D Y Song T L DeWeese P T Tran P C Walsh Source Type: research

Treatment of M1a/M1b prostate cancer with or without radical prostatectomy at diagnosis
J Karnes (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 3, 2017 Category: Urology & Nephrology Authors: M Moschini A Morlacco E Kwon L J Rangel R J Karnes Source Type: research

Skeletal-related events significantly impact health-related quality of life in metastatic castration-resistant prostate cancer: data from PREVAIL and AFFIRM trials
S Holmstrom (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 3, 2017 Category: Urology & Nephrology Authors: F Saad C Ivanescu D Phung Y Loriot S Abhyankar T M Beer B Tombal S Holmstrom Source Type: research

Updated postoperative nomogram incorporating the number of positive lymph nodes to predict disease recurrence following radical prostatectomy
; K A Touijer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - December 13, 2016 Category: Urology & Nephrology Authors: D P Nguyen M Kent A Vilaseca R B Corradi N Fossati D D Sjoberg N Benfante J A Eastham P T Scardino K A Touijer Source Type: research

Blood-based and urinary prostate cancer biomarkers: a review and comparison of novel biomarkers for detection and treatment decisions
halken (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - December 6, 2016 Category: Urology & Nephrology Authors: R J Hendriks I M van Oort J A Schalken Source Type: research

Adaptation and external validation of the European randomised study of screening for prostate cancer risk calculator for the Chinese population
amp; C F Ng (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 29, 2016 Category: Urology & Nephrology Authors: P K Chiu M J Roobol D Nieboer J Y Teoh S K Yuen S M Hou M K Yiu C F Ng Source Type: research

The prognostic role of tertiary Gleason pattern 5 in a contemporary grading system for prostate cancer
mp; Y D Choi (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 15, 2016 Category: Urology & Nephrology Authors: W S Jang C Y Yoon M S Kim D H Kang Y J Kang W S Jeong M J Abalajon W S Ham Y D Choi Source Type: research

The role of salvage extended lymph node dissection in patients with rising PSA and PET/CT scan detected nodal recurrence of prostate cancer
Heidenreich (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 8, 2016 Category: Urology & Nephrology Authors: D Porres D Pfister A Thissen T H Kuru V Zugor R Buettner R Knuechel F A Verburg A Heidenreich Source Type: research

Duration of the anti-androgen in men undergoing 6 months of an LHRH agonist and radiation therapy for unfavorable-risk prostate cancer and the risk of death
V D'Amico (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 8, 2016 Category: Urology & Nephrology Authors: N N Sanford M-H Chen M Loffredo A Renshaw P W Kantoff A V D'Amico Source Type: research

Active surveillance for intermediate-risk prostate cancer
Klotz (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 1, 2016 Category: Urology & Nephrology Authors: M A Dall'Era L Klotz Source Type: research

Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis
ke, F Feng & A E Ross (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 1, 2016 Category: Urology & Nephrology Authors: B Benzon S G Zhao M C Haffner M Takhar N Erho K Yousefi P Hurley J L Bishop J Tosoian K Ghabili M Alshalalfa S Glavaris B W Simons P Tran E Davicioni R J Karnes K Boudadi E S Antonarakis E M Schaeffer C G Drake F Feng A E Ross Source Type: research

The impact of local treatment of the primary tumor site in node positive and metastatic prostate cancer patients
Shariat (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 25, 2016 Category: Urology & Nephrology Authors: M Moschini F Soria A Briganti S F Shariat Source Type: research

SOCS1 inhibits migration and invasion of prostate cancer cells, attenuates tumor growth and modulates the tumor stroma
S Ilangumaran (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 25, 2016 Category: Urology & Nephrology Authors: A Villalobos-Hernandez D Bobbala R Kandhi M G M Khan M Mayhue C M Dubois G Ferbeyre C Saucier S Ramanathan S Ilangumaran Source Type: research

Does prostate volume correlate with vitamin D deficiency among men undergoing prostate biopsy?
& R Kittles (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 11, 2016 Category: Urology & Nephrology Authors: A B Murphy Y A Nyame K Batai R Kalu A Khan P Gogana M Dixon V Macias A Kajdacsy-Balla C M P Hollowell W J Catalona R Kittles Source Type: research

Obesity and prostate cancer-specific mortality after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database
J Freedland (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 4, 2016 Category: Urology & Nephrology Authors: A C Vidal L E Howard S X Sun M R Cooperberg C J Kane W J Aronson M K Terris C L Amling S J Freedland Source Type: research